Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prasugrel vs clopidogrel for branch atheromatous disease progression
jRCT1041220038Completed
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in ischemic stroke and branch atheromatous disease (BAD) comparing Prasugrel arm with Clopidogrel arm (2 arms). Primary endpoint: Early neurological deterioration within 7 days. Started Sep 2022; status: completed.
02
Drugs
prasugrelclopidogrel
03
Conditions
ischemic strokebranch atheromatous disease (BAD)
Beyond the preview
Go deeper on jRCT1041220038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041220038.